SPC273
Samsetning af glýkópýrrólati (að meðtöldum öllum lyfjafræðilega viðunandi söltum, esterum, handhverfum eða öðrum afleiðum þar af) og formóteróli (að meðtöldum öllum lyfjafræðilega viðunandi söltum, esterum, handhverfum eða öðrum afleiðum þar af)
Status:
VeittApplication date:
6.6.2019Application published:
15.7.2019Grant published:
15.6.2022
Max expiry date:
19.12.2033Medicine name:
Bevespi AerosphereMedicine for children:
No
Timeline
Today
6.6.2019Application
15.7.2019Publication
15.6.2022Registration
19.12.2033Expires
Marketing license
IS authorization number:
EU/1/18/1339/001Date:
9.1.2019
Foreign authorization number:
EU/1/18/1339Date:
18.12.2018
Owner
Name:
Pearl Therapeutics, Inc.Address:
200 Saginaw Drive, Redwood City, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2435025